BioSpace News Archive

FDA

FDA Grants State-Licensed Pharmacists Authority to Prescribe Pfizer’s Paxlovid

The granting of the EUA comes with certain limitations, as the prescribing pharmacist must refer patients for clinical assessment with a physician.

July 7, 2022
·
2 min read
·
Vanessa Doctor, RN
Research Roundup: a Potential Vaccine for ALS & More

Researchers and biotech companies are working on developing vaccines and therapies for cancer, ALS, COVID-19, obesity and psoriasis. Here’s a look at just some of them.

July 7, 2022
·
5 min read
·
Mark Terry
Drug Development

Portage Adds Four Adenosine Candidates to Pipeline in Tarus Buyout

Portage Biotech announced Wednesday that it has inked an acquisition agreement with New York-based Tarus Therapeutics, adding four new candidates to its pipeline.

July 7, 2022
·
3 min read
·
Tristan Manalac
Business

Haleon will Launch with $12B+ Debt as New GSK Gains Momentum

When GSK’s consumer health spinoff Haleon launches later this month, the new business will carry more than $12 billion in debt when it lists on the London Stock Exchange.

July 7, 2022
·
2 min read
·
Alex Keown
Insilico’s AI Identifies Potential New Therapeutic Targets for ALS

The quest to develop a new treatment approach to amyotrophic lateral sclerosis (ALS) may soon be shortened due to the discovery of new potential therapeutic targets by Insilico Medicine.

July 7, 2022
·
2 min read
·
Alex Keown
Drug Development

Following Breast Cancer Fail, CytomX Slashes Workforce by 40% - UPDATED

CytomX Therapeutics is shifting its focus to preclinical and early clinical studies, emphasizing alliances and slashing its workforce by about 40% to extend cash flow to 2025.

July 7, 2022
·
3 min read
·
Vanessa Doctor, RN
Policy

AbbVie’s Tax Structure in Crosshairs of Senate Finance Committee Report

A Senate Finance Committee report shows the majority of AbbVie’s income is taxed through foreign subsidiaries, allowing the company to pay less than half the U.S. corporate tax rate.

July 7, 2022
·
3 min read
·
Alex Keown
Japanese Study Suggests Parasitic Worms could Deliver Anti-Cancer Therapies

Researchers from Osaka University have released details on how they discovered a unique, albeit strange, potential treatment method for cancer - parasitic worms.

July 7, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

Lysogene Gene Therapy Indicates Potential to Slow Sanfilippo Syndrome

Lysogene’s Phase II/III trial assessing LYS-SAF302 for the treatment of MPS IIIA, also known as Sanfilippo syndrome type A, revealed positive biomarker data, spurring hope for a potential treatment.

July 7, 2022
·
3 min read
·
Heather McKenzie
Drug Development

Intercept, Annovis and Biohaven Advance Late Phase Trials

Intercept Pharmaceuticals, Annovis Bio and Biohaven Pharma are moving forward with late-stage Phase III clinical trials.

July 7, 2022
·
3 min read
·
Mark Terry